Moreno-Navarette et al. suggested that Omentin, after controlling for adiposity, age, and inflammation in patients with impaired glucose tolerance, contributed independently to endothelial dysfunction [13]. The gene discussed is ITLN1; the disease is endothelial dysfunction.